News

Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Announces Prominent Coverage in Brazilian Newspapers After Legal Victory

October 25, 2017

general_hemp_blog_images_03-01-17_ver1

Federal Judge in Brazil Orders the Government to Subsidize Payments for Real Scientific Hemp Oil™ (RSHO™) for Brazilian Citizen SAN DIEGO, Oct. 24, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today subsidiary HempMeds®

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Applauds Establishment of Patient Association in Brazil to Provide Cannabis Patients Greater Access

October 2, 2017

general_hemp_blog_tech_medicine_02-02-17_ver1

SAN DIEGO, Oct. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is excited to support the establishment of the Associação Nacional dos usuários de Canabidiol (ANUC) Patient Association in Brazil dedicated to

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Sponsor 8th ABN-RJ/ANERJ Congress in Rio de Janeiro

September 26, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Sept. 26, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is proud to sponsor the 8th Brazilian Academy of Neurology/Association of Neurology of

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil’s Sold-Out Doctor Symposium on Medical Cannabis Garners Vast Media Coverage Across Brazil

August 23, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Aug. 23, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil held a successful, sold-out Doctor Symposium in Sao Paulo, Brazil on August 15, with 50 doctors in attendance, which garnered vast media

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Its Second Doctor Symposium on Medical Cannabis in Sao Paulo, Brazil

August 14, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Aug. 14, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is holding a sold-out doctor symposium in Sao Paulo, Brazil, dedicated to providing the Brazilian medical community with information about the

Amyotrophic Lateral Sclerosis (ALS) and Psoriasis Patients Receive Brazilian Government Permission to Be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

July 19, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, July 19, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) is the first publicly traded cannabis company in the United States. Its subsidiary HempMeds® Brasil today announced that the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ [RSHO™] has been prescribed by doctors in the country for the treatment

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country’s First-Ever Symposium On Medical Cannabis For Health Professionals

March 30, 2017

general_hemp_blog_images_03-01-17_ver1

Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States, today

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

March 1, 2017

general_hemp_blog_images_03-01-17_ver1 (1)

SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

March 1, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real

Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

February 23, 2017

general-hemp-blog-images-17-01-05-ver1

SAN DIEGO, Feb. 21, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product